Novel mechanisms for antisense-mediated regulation of gene expression.
Baker
B F
BF
Department of Molecular Pharmacology, Isis Pharmaceuticals, Carlsbad, CA 92008, USA.
Monia
B P
BP
D017398:Alternative Splicing / Q000187:drug effects; D000818:Animals; D002474:Cell-Free System / Q000378:metabolism; D004722:Endoribonucleases / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D009693:Nucleic Acid Hybridization / Q000187:drug effects / Q000235:genetics; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects; D020135:Peptide Nucleic Acids / Q000494:pharmacology; D014176:Protein Biosynthesis / Q000187:drug effects; D012313:RNA / Q000737:chemistry / Q000378:metabolism*; D012323:RNA Processing, Post-Transcriptional / Q000187:drug effects; D016372:RNA, Antisense / Q000378:metabolism* / Q000494:pharmacology; D016337:RNA, Catalytic / Q000378:metabolism; D016914:Ribonuclease H / Q000378:metabolism; D043262:Ribonuclease P
D020135:Peptide Nucleic Acids; D016372:RNA, Antisense; D016337:RNA, Catalytic; D012313:RNA; D004722:Endoribonucleases; C031956:2-5A-dependent ribonuclease; D016914:Ribonuclease H; C468368:RPP14 protein, human; D043262:Ribonuclease P